CIBC Bancorp USA’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
CIBC Bancorp USA's OCUL Position: Q3 2026 in Review
CIBC Bancorp USA increased its Ocular Therapeutix (OCUL) stake by 51% in Q3 2026, buying an estimated $97.6K and bringing the position to 29,374 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1898.
CIBC Bancorp USA first reported a position in OCUL in Q3 2025 and has held it in 4 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- CIBC Bancorp USA held 29,374 shares of Ocular Therapeutix worth $225K as of Q3 2026.
- CIBC Bancorp USA bought 9,966 Ocular Therapeutix shares in Q3 2026, an estimated $97.6K.
- Ocular Therapeutix made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1898 holding.
- CIBC Bancorp USA first reported a position in Ocular Therapeutix in Q3 2025 and has held it in 4 quarters since.
- 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.